About NBR“Nightly Business Report produced by CNBC” (NBR) is an award-winning and highly-respected nightly business news program that airs on public television. Television’s longest-running evening business news broadcast, “NBR” features in-depth coverage and analysis of the biggest financial news stories of the day and access to some of the world’s top business leaders and policy makers.
NBR on TwitterMy Tweets
Our Market Monitor guest tonight says investors should buy this dip. He’s optimistic about stocks and not worried about the recent sell-offs.
U.S. stocks on Wednesday climbed for a third session after U.S. industrial production rose more than projected, Yahoo’s earnings topped estimates and Federal Reserve Chair Janet Yellen reiterated the central bank would keep up its backing of the recovery. Stocks held most of their gains as Federal Reserve Chair Janet Yellen addressed the Economic Club …
Stocks rallied and stayed there after Fed Chief Janet Yellen spoke. What did she say that the market seems to like?
Wells Fargo’s Chief International Investment Strategist, Paul Christopher gives us analysis on the escalating tensions in Ukraine and what it means for the markets.
Do you own a neck brace? If not, you might want to consider getting one. Or visiting a chiropractor. Market Watchers haven’t seen ups and downs like today’s in a couple of years. It was wild. Stocks were up early, then down hard on Ukraine worries, then bungeed up into the close on lighter than …
What caused the whipsaw day on Wall Street and can we expect more volatility in the coming weeks and months? For this story and more tune in tonight.
Even though stocks rallied today, there’s still a lively debate between bulls and bears on Wall Street on Wall Street. Tonight we hear from both sides, Michael Farr, President of Farr Miller and Washington is bullish and Barry James, President of James Advantage Funds is bearish.
U.S. stocks advanced Monday, after the Nasdaq Composite briefly detoured into negative terrain, as investors embraced data that had U.S. retail sales jumping the most since 2012 while tracking tensions in Ukraine. “We’re hopeful that today’s upward price action is not confined, but we’re also cognizant of continued unrest in that geography,” Jim Russell, senior …
Stronger earnings at Citigroup, the best retail sales gain in 18 months and the cooing of dovish European central bankers combined to turn the tide for stocks, even as worries about Ukraine hang over markets. Stocks jumped out of the gate Monday morning but pulled back from the highs that initially sent the Dow up triple digits. …
Two banks; JPMorgan Chase and Wells Fargo reported first quarter earnings. Profits at JP fell by one-fifth while net profit at Wells Fargo topped more than $6 billion here’s a look at what’s behind those disparate earnings results.
Is the bull market still alive? After a wild week on Wall Street, see what one market watcher says you should do with your money now.
The tidal wave of initial public offerings (IPO) has now dried up as the market reels. Out of eight IPOs set to price last night, four got put on hold. Those that failed to get out the door: Lombard Medical (EVAR)—which cited the dreaded “poor market conditions” according to Renaissance Capital—SCYNEXIS (SCYX), Paycom Software (PAYC), and City …
U.S. stocks were slammed on Thursday, with high-flying technology and biotech shares leading the declines that had the Nasdaq Composite posting its worst session in more than two years. “The market is coming to its senses in some of the high-flying tech names; it looked like there were some pretty hefty amounts being paid for …
The Dow drops more than 250 points. The Nasdaq has its worst day in almost three years. The reason? No one can explain it. For this story and more tune in tonight.
U.S. stocks were slammed on Thursday, with biotechnology and technology shares resuming declines that had both the Dow and the Nasdaq Composite down triple digits, as investors fled high-flying technology and biotech shares in favor of defensive plays. “Clearly investors are nervous about high-flying momentum stocks. There is a rethink on whether better earnings and …